Alira Health France has been granted Innovation and Research Provider status by the Ministry of Research

Paris, France – September 14, 2018

We are proud to announce that Alira Health France has been granted Innovation and Research Provider status as part of The Research Tax Credit (RTC)/Crédit Impôt Recherche (CIR) initiative.

This designation, issued by the French Ministry of Research, enables Alira Health’s clients operating in France to deduct part of their investment in Research & Development projects from their taxes.

“Having Innovation and Research Provider status gives our current and future clients the ability to deduct 30 percent of our costs from their taxes when it comes to spending in R&D,” explains Benjamin Chambon, Chief Operating Officer of Alira Health.

The RTC/CIR was created to help support firms’ Research & Development efforts, increasing competitiveness and driving innovation. Eligible projects include fundamental and applied research, as well as experimental development.

“Alira Health is the only healthcare consultancy with Innovation and Research Provider status,” Alira Health Chief Executive Officer Gabriele Brambilla notes. “Innovation is at the core of what we do, from our Drug and Device Discovery Lab to our in-house Incubator. This credential is a significant benefit that we can offer our clients to support their innovations.”

To learn more about how Alira Health and the Research Tax Credit program can help support your Research & Development projects, please contact

Benjamin Chambon

Chief Operating Officer

benjamin.chambon@alirahealth.com

 

 

CONNECT WITH ALIRA HEALTH

To receive new information, thought-provoking whitepapers, and opportunities to connect with healthcare experts on everything from regulatory and clinical trial challenges to strategy and financing solutions, we invite you to join our email list.